Development and validation of a risk prediction score for the severity of acute hypertriglyceridemic pancreatitis in Chinese patients

Table 5 The relationship between risk stratification and clinical parameters

	Low-risk group (n = 158)		High-risk group (n = 85)	P value
Local complications
APFC	43 (27.22%)	68 (80.00%)		< 0.001
PPC	3 (1.90%)	10 (11.77%)		0.001
ANC	3 (1.90%)	22 (25.88%)		< 0.001
WON	0 (0.00%)	4 (4.71%)		0.014
Systemic complications
SIRS	92 (58.23%)	72 (84.71%)		< 0.001
Respiratory failure	29 (18.35%)	59 (69.41%)		< 0.001
Renal failure	0 (0.00%)	13 (15.29%)		< 0.001
Cardiovascular failure	2 (1.27%)	5 (5.88%)		0.040
Clinical Scoring Systems
Ranson ≥ 3	28 (17.72%)	53 (62.35%)		< 0.001
BISAP ≥ 3	0 (0.00%)	4 (4.71%)		0.014
MCTSI ≥ 4	15 (9.49%)	53 (62.35%)		< 0.001
APACHE-II ≥ 8	73 (46.20%)	68 (80.00%)		< 0.001
CRP ≥ 190	42 (26.58%)	44 (51.77%)		< 0.001
Hospital day, days	13.51 ± 5.45	20.04 ± 8.14		< 0.001

APFC: Acute peripancreatic fluid collection; PPC: Pancreatic pseudocyst; ANC: Acute necrotic collection; WON: Walled-off necrosis; IPN: Infected pancreatic necrosis; SIRS: Systemic inflammatory response syndrome.